Upadacitinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 March 2025

  • curprev 20:4720:47, 9 March 2025 Omid Afkhami-Ardakani talk contribs 9,728 bytes +9,728 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Upadacitinib |aOrAn=a |drugClass=Janus Kinase (JAK) Inhibitor |indicationType=treatment |indication=Moderate to severe active rheumatoid arthritis, Active psoriatic arthritis, Moderate to severe atopic dermatitis, Moderate to severe ulcerative colitis, Moderate to severe active Crohn's disease, Active ankylosing spondylitis, and Active non-radiographic axial spondyloarthritis. |hasBlackBoxWarning=Y..."